Skip to main content
Year archive

Abliva — 2016 filings

All 72 regulatory filings released by Abliva (ABLI) in 2016, sourced directly from the official regulator.

72 Filings
2016 Period
2016 filings (72)
Filing Released Lang
Earnings Release 2016
Earnings Release 9M 2016
2016-11-22 Swedish
Interim / Quarterly Report 2016
Interim / Quarterly Report 9M 2016
2016-11-22 English
NeuroVives rekrytering av Michele Tavecchio stärker forskningsorganisationen
Board/Management Information
2016-11-08 Swedish
NeuroVive’s recruitment of Michele Tavecchio strengthens its research organization
Board/Management Information
2016-11-08 English
NeuroVive rapporterar positiva prekliniska resultat i NASH
Regulatory Filings
2016-11-01 Swedish
NeuroVive reports positive pre-clinical results in NASH
Regulatory Filings
2016-11-01 English
NeuroVive Pharmaceutical AB: Årsstämma 2017 och valberedning
AGM Information
2016-10-26 Swedish
NeuroVive Pharmaceutical AB: Annual General Meeting 2017 and Nomination Committee
AGM Information
2016-10-26 English
NeuroVive completes closure of Lyon subsidiary
Regulatory Filings
2016-10-25 English
NeuroVive fullföljer nedläggning av dotterbolag i Lyon
Regulatory Filings
2016-10-25 Swedish
NeuroVive och Arbutus tecknar termineringsavtal
M&A Activity
2016-10-21 Swedish
NeuroVive and Arbutus sign termination agreement
Regulatory Filings
2016-10-21 English
NeuroVive avbryter utvecklingen av CicloMulsion för akut njurskada
Earnings Release FY 2016
2016-10-13 Swedish
NeuroVive discontinues development of CicloMulsion for acute kidney injury
Regulatory Filings
2016-10-13 English
NeuroVive to Present at the Rodman & Renshaw 18th Annual Global Investment Conference
Investor Presentation
2016-09-07 English
NeuroVive presenterar på Rodman & Renshaw 18th Annual Global Investment Conference
Investor Presentation
2016-09-07 Swedish
NeuroVive meddelar att den kliniska studien CiPRICS presenteras på Svenska Thorax-mötet i oktober 2016
Regulatory Filings
2016-08-30 Swedish
NeuroVive announces that the clinical study CiPRICS will be presented at the Swedish Thorax meeting in October 2016
Regulatory Filings
2016-08-30 English
NeuroVives operative chef Jan Nilsson lämnar bolaget
Board/Management Information
2016-08-24 Swedish
NeuroVive’s Chief Operating Officer Jan Nilsson leaves the company
Board/Management Information
2016-08-24 English
Interim / Quarterly Report 2016
Interim / Quarterly Report H1 2016
2016-08-18 Swedish
Interim / Quarterly Report 2016
Interim / Quarterly Report H1 2016
2016-08-18 English
NeuroVive fullföljer 10 procents delförvärv av Isomerase Therapeutics
Capital/Financing Update
2016-08-15 Swedish
NeuroVive completes 10 percent acquisition of Isomerase Therapeutics
Capital/Financing Update
2016-08-15 English
NeuroVives nya strategi för behandling av mitokondriell sjukdom publicerad i Nature Communications
Regulatory Filings
2016-08-09 Swedish
NeuroVive’s novel strategy for treatment of mitochondrial disease published in Nature Communications
Regulatory Filings
2016-08-09 English
NeuroVive informerar om Arbutus Biopharmas uppsägning av licensavtalet
Legal Proceedings Report
2016-07-06 Swedish
NeuroVive announces Arbutus Biopharma’s notice of termination
Legal Proceedings Report
2016-07-06 English
NeuroVive announces CiPRICS study completes enrolment
Regulatory Filings
2016-06-07 English
NeuroVive meddelar att CiPRICS-studien är fullrekryterad
Regulatory Filings
2016-06-07 Swedish
Major Shareholding Notification 2016
Major Shareholding Notification
2016-06-02 English
NeuroVives aktie uppgraderas till OTC Markets Group – OTCQX Best Market i USA
Regulatory Filings
2016-06-02 Swedish
NeuroVive share upgraded to OTC Markets Group – OTCQX Best Market in the US
Capital/Financing Update
2016-06-02 English
Major Shareholding Notification 2016
Major Shareholding Notification
2016-06-01 English
NeuroVive Pharmaceutical AB (publ) - amendment number of shares and votes
Share Issue/Capital Change
2016-05-31 English
Ändring av antal aktier och röster i NeuroVive Pharmaceutical AB (publ)
Declaration of Voting Results & Voting Rights Announcements
2016-05-31 Swedish
Interim / Quarterly Report 2016
Interim / Quarterly Report Q1 2016
2016-05-31 Swedish
Interim / Quarterly Report 2016
Interim / Quarterly Report Q1 2016
2016-05-31 English
Uppdaterad tidplan för omvandling av NeuroVives BTU till aktier och teckningsoptioner
Capital/Financing Update
2016-05-23 Swedish
Updated timeline for conversion of NeuroVive’s BTUs into shares and warrants
Capital/Financing Update
2016-05-23 English
NeuroVive preferential rights issue fully subscribed
Capital/Financing Update
2016-05-10 English
Företrädesemissionen i NeuroVive fulltecknad
Capital/Financing Update
2016-05-10 Swedish
Kommuniké från årsstämma i NeuroVive Pharmaceutical AB (publ)
AGM Information
2016-04-29 Swedish
NeuroVive Pharmaceutical AB (publ): Report from AGM
AGM Information
2016-04-29 English
NeuroVives R&D-team kommer att presentera forskningsframsteg vid vetenskaplig konferens om mitokondriell medicin
Regulatory Filings
2016-04-28 Swedish
NeuroVive’s R&D Team to Present Research Progress at Mitochondrial Medicine Conference
Regulatory Filings
2016-04-28 English
NeuroVive: Insynspersoner och anställda avser teckna för minst 5,4 MSEK
Share Issue/Capital Change
2016-04-26 Swedish
NeuroVive insiders and employees intend to subscribe for a minimum of 5.4 million SEK
Share Issue/Capital Change
2016-04-26 English
NeuroVive: storägare avser deltaga i företrädesemissionen
Capital/Financing Update
2016-04-18 Swedish
NeuroVive: large shareholder to participate in the rights issue
Share Issue/Capital Change
2016-04-18 English
NeuroVive offentliggör publicering av prospekt och meddelar om ändrat datum för publicering av kvartalsrapport 1, 2016
Capital/Financing Update
2016-04-14 Swedish
NeuroVive publishes prospectus and announces new publication date of the Q1 interim report
Report Publication Announcement
2016-04-14 English
NeuroVive förstärker organisationen med Cecilia Hofvander som ansvarig för IR och kommunikation
Board/Management Information
2016-04-11 Swedish
NeuroVive strengthens its organization with the recruitment of Cecilia Hofvander as IR and Communications Director
Board/Management Information
2016-04-11 English
Annual Report 2015
Annual Report FY 2015
2016-04-07 Swedish
Annual Report 2015
Annual Report FY 2015
2016-04-07 English
NeuroVive Pharmaceutical AB (publ): kommuniké från extra bolagsstämma
AGM Information
2016-03-31 Swedish
NeuroVive Pharmaceutical AB (publ): report from EGM
AGM Information
2016-03-31 English
Kallelse till årsstämma i NeuroVive Pharmaceutical AB (publ)
AGM Information
2016-03-29 Swedish
Notice of Annual General Meeting of NeuroVive Pharmaceutical AB (publ)
AGM Information
2016-03-29 English
NeuroVive meddelar att CiPRICS-studien passerar säkerhetsutvärdering efter 100 inkluderade patienter
Regulatory Filings
2016-03-14 Swedish
NeuroVive announces the CiPRICS study enrols 100 patients and reports favourable safety evaluation
Legal Proceedings Report
2016-03-14 English
Kallelse till extra bolagsstämma i NeuroVive Pharmaceutical AB (publ)
AGM Information
2016-02-29 Swedish
Notice of extraordinary general meeting in NeuroVive Pharmaceutical AB (publ)
AGM Information
2016-02-29 English
Styrelsen utser Erik Kinnman till ny VD för NeuroVive
Board/Management Information
2016-02-23 Swedish
Board Selects New CEO Erik Kinnman to Lead NeuroVive
Board/Management Information
2016-02-23 English
Earnings Release 2015
Earnings Release Q4 2015
2016-02-19 Swedish
Interim / Quarterly Report 2015
Interim / Quarterly Report FY 2015
2016-02-19 English
NeuroVive buys stake in Isomerase Therapeutics
Regulatory Filings
2016-01-14 English
NeuroVive förvärvar andel av Isomerase Therapeutics
Share Issue/Capital Change
2016-01-14 Swedish
NeuroVive tecknar strategiskt samarbetsavtal med University of Pennsylvania
Regulatory Filings
2016-01-12 Swedish
NeuroVive enters strategic collaboration with University of Pennsylvania
Regulatory Filings
2016-01-12 English